Richard I Steinhart Net Worth - Insider Trades and Bio as of Jun 6, 2026

BTAIBioXcel Therapeutics, Inc.SEC CIK: 0001293789

Estimated Net Worth

$620 Thousand

Last Updated: May 19, 2026 11:13 PM EST

Transaction Summary

Total Transactions72

Buy-Sell Ratio0.75

Buy Transactions6

Sell Transactions8

Transaction Volume

Total Volume-$173.31K

Net Volume$514.56K

Buy Volume$170.62K

Sell Volume-$343.94K

Trade Analysis

AVG Trade Size$6.65K

Largest Trade$334.67K

Most Active MonthMay

Most Active Year2025

Trading Sentiment

OverallBullish

Recent TradeNeutral

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Richard I Steinhart does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include MANHATTAN PHARMACEUTICALS INC, BioXcel Therapeutics, Inc., Actinium Pharmaceuticals, Inc., MELA SCIENCES, INC. /NY, and ATOSSA THERAPEUTICS, INC..

2025 was Richard I Steinhart's most active year for acquiring shares with 13 total transactions. Richard I Steinhart's most active month to acquire stocks was the month of February. 2025 was Richard I Steinhart's most active year for disposing of shares, totalling 17 transactions. Richard I Steinhart's most active month to dispose stocks was the month of February. 2013 saw Richard I Steinhart paying a total of $337,092.00 for 235,754 shares, this is the most they've acquired in one year. In 2021 Richard I Steinhart cashed out on 7,500 shares for a total of $180,562.50, their largest year based on trade value.

Holdings & Transactions

BTAIbioxcel therapeutics, inc.

Chief Financial Officer Officer

Updated: May 07, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	May 07, 2026	15.65K	Options	—	May 01	View
From 4	—	—	—	—	Mar 16, 2026	6.99K	Options	—	Mar 14 - 15	View
From 4	248.23	70.00K	—	—	Jan 05, 2026	70.28K	Grant	—	Jan 01	View
From 4	—	—	—	—	Dec 15, 2025	6.99K	Options	—	Dec 14 - 15	View
From 4	—	—	—	—	Sep 16, 2025	6.99K	Options	—	Sep 14 - 15	View
From 4	—	9.00K	—	—	Aug 05, 2025	9.00K	Grant	—	Aug 01	View
From 4	2.12	4.38K	—	—	Jul 22, 2025	6.44K	Options	—	Jul 22	View
From 4	—	—	—	—	Jun 16, 2025	1.99K	Options	—	Jun 14 - 15	View
From 4	—	2.50K	—	—	Apr 01, 2025	2.50K	Grant	—	Jul 22	View
From 4	—	—	—	—	Mar 17, 2025	1.99K	Options	—	Mar 14 - 15	View
From 4	—	270.00K	—	—	Jan 10, 2025	270.00K	Grant	—	Jan 07	View
From 4	-0.01	577.00	$0.36	-$206.98	Dec 17, 2024	49.76K	Sale	Scheduled	Dec 14 - 16	View
From 4	2.27	14.07K	$0.55	-$3.95K	Oct 03, 2024	20.28K	Grant	Scheduled	Sep 17 - 03	View
From 4	-0.02	356.00	$0.69	-$245.60	Sep 17, 2024	14.96K	Sale	Scheduled	Sep 14 - 16	View
From 4	-0.02	372.00	$1.26	-$469.54	Jun 18, 2024	15.31K	Sale	Scheduled	Jun 14 - 17	View
From 4	-0.06	1.07K	$2.64	-$2.82K	Apr 08, 2024	15.68K	Sale	Scheduled	Mar 14 - 04	View
From 4	—	—	—	—	Dec 18, 2023	7.75K	Options	—	Dec 14	View
From 4	—	—	—	—	Sep 18, 2023	7.75K	Options	—	Sep 14	View
From 4	—	—	—	—	Jun 16, 2023	7.75K	Options	—	Jun 14	View
From 4	-0.77	5.00K	$27.17	-$135.86K	May 16, 2023	1.50K	Sale	—	May 14 - 15	View
From 4	3.96	38.92K	$19.50	-$40.64K	Mar 16, 2023	48.75K	Sell-Options	Scheduled	Mar 14 - 15	View
From 4	—	5.00K	—	—	May 17, 2022	5.00K	Grant	—	May 14	View
From 4	—	41.69K	—	—	Mar 16, 2022	41.69K	Grant	—	Mar 14	View
From 4	—	20.00K	—	—	Mar 29, 2021	20.00K	Grant	—	Mar 25	View
From 4	-0.04	3.75K	$26.85	-$159.75K	Feb 03, 2021	81.65K	Sale	Scheduled	Feb 01	View
From 4	—	55.00K	—	—	May 28, 2020	55.00K	Grant	—	May 26	View
From 4	0.50	500.00	$5.20	$2.60K	Dec 04, 2018	1.50K	Purchase	—	Dec 03	View
From 4	1.00	500.00	$5.00	$2.50K	Nov 30, 2018	1.00K	Purchase	—	Nov 30	View
From 4	—	500.00	$5.00	$2.50K	Nov 30, 2018	500.00	Purchase	—	Nov 29	View
From 4	0.38	32.23K	—	—	Mar 13, 2018	116.13K	Grant	—	Mar 12	View
From 3	—	—	—	—	Mar 07, 2018	—	—	—	—	View

ATOSatossa therapeutics, inc.

Updated: May 14, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	10.00K	—	—	May 14, 2026	10.00K	Grant	—	May 12	View
From 4	—	125.00K	—	—	May 16, 2025	125.00K	Grant	—	May 15	View
From 4	—	125.00K	—	—	Jul 01, 2024	125.00K	Grant	—	Jun 27	View
From 4	—	125.00K	—	—	May 05, 2023	125.00K	Grant	—	May 04	View
From 4	0.11	50.00K	—	—	May 16, 2022	500.00K	Grant	—	May 13	View
From 4	—	50.00K	—	—	May 18, 2021	50.00K	Grant	—	May 14	View
From 4	—	45.00K	—	—	May 19, 2020	45.00K	Grant	—	May 15	View
From 4	—	45.00K	—	—	May 21, 2019	45.00K	Grant	—	May 17	View
From 4	—	45.00K	—	—	Jun 29, 2018	45.00K	Grant	—	Jun 27	View
From 4	5.20	49.53K	—	—	May 26, 2017	59.06K	Grant	—	May 24	View
From 4	—	71.48K	—	—	May 19, 2016	71.48K	Grant	—	May 18	View
From 4	—	40.00K	—	—	May 14, 2015	40.00K	Grant	—	May 12	View
From 4	-0.34	7.73K	—	—	May 08, 2014	15.00K	Disposition	—	May 06	View
From 4	—	39.21K	—	—	Mar 04, 2014	39.21K	Grant	—	Mar 01	View
From 3	—	—	—	—	Mar 04, 2014	—	—	—	—	View

ATNMactinium pharmaceuticals, inc.

Updated: Apr 02, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	184.98K	—	—	Apr 02, 2025	—	Disposition	—	Mar 31	View
From 4	—	70.31K	—	—	Dec 29, 2023	70.31K	Grant	—	Dec 28	View
From 4	—	72.16K	—	—	Jul 01, 2022	72.16K	Grant	—	Jul 01	View
From 4	—	18.35K	—	—	Sep 03, 2021	18.35K	Grant	—	Sep 01	View
From 4	—	8.33K	—	—	Aug 14, 2020	8.33K	Grant	—	Aug 12	View
From 4	—	250.00K	$0.23	$58.00K	Jul 16, 2019	250.00K	Grant	—	Jul 12	View
From 4	—	75.00K	$0.78	$58.72K	Jul 17, 2018	75.00K	Grant	—	Jul 13	View
From 4	5.60	14.00K	$0.50	$7.00K	Mar 08, 2018	16.50K	Acquisition	—	Mar 06	View
From 4	—	75.00K	$1.39	$104.25K	Mar 16, 2017	75.00K	Grant	—	Mar 14	View
From 4	—	77.50K	$2.00	$154.28K	Apr 18, 2016	77.50K	Purchase	—	Apr 14 - 15	View
From 4	—	25.00K	$3.58	$89.50K	Mar 16, 2015	25.00K	Grant	—	Feb 18	View
From 4	—	49.95K	$6.70	$334.67K	Dec 24, 2013	49.95K	Grant	—	Dec 16	View
From 3	—	—	—	—	Nov 13, 2013	—	—	—	—	View

SSKNmela sciences, inc. /ny

Chief Financial Officer Officer

Updated: Aug 08, 2013VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	181.30K	—	—	Aug 08, 2013	181.30K	Grant	—	Aug 05	View
From 4	3.00	3.00K	$0.81	$2.43K	Jun 25, 2013	4.00K	Purchase	—	Jun 25	View
From 4	—	1.50K	—	—	Apr 26, 2013	1.50K	Grant	—	Apr 25	View
From 4	—	100.00K	—	—	Apr 26, 2011	100.00K	Grant	—	Apr 25	View
From 4	—	1.00K	$6.32	$6.32K	Aug 12, 2010	1.00K	Purchase	—	Aug 12	View
From 4	—	16.50K	—	—	May 14, 2010	16.50K	Grant	—	May 13	View
From 3	—	—	—	—	May 02, 2006	—	—	—	—	View

TGTXmanhattan pharmaceuticals inc

Updated: Mar 10, 2010VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	300.00K	—	—	Mar 10, 2010	521.64K	Grant	—	Mar 03	View
From 4	—	75.00K	—	—	Mar 28, 2008	216.01K	Grant	—	Mar 25	View
From 4	—	55.63K	—	—	Jan 31, 2007	146.64K	Grant	—	Jan 30	View
From 4	—	11.01K	—	—	Feb 22, 2005	91.01K	Grant	—	Jan 11	View
From 4	—	80.00K	—	—	Sep 28, 2004	80.00K	Grant	—	Sep 27	View
From 3	—	—	—	—	Sep 02, 2004	—	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions